A Medical Device Daily
Zoll Medical (Chelmsford, Massachusetts), a manufacturer of resuscitation devices and related software solutions, reported that Basingstoke and North Hampshire Hospital (Hampshire, UK) is the first hospital to install the AutoPulse non-invasive cardiac support pump in the cardiac catheterization laboratory in the UK.
"Providing high-quality CPR in a cath lab is challenging, especially without proper positioning due to the way a cath lab table is built on a pedestal base. Providing chest compressions during interventional catheterization can expose staff to significant radiation," said Carl Brookes, MD, consultant cardiologist for Basingstoke and North Hampshire. "Using the AutoPulse solves the challenge staff face in providing CPR while the cath lab table is off its pedestal base, which can cause damage to the table and subsequently endanger the patient."
"Moreover, with our new process of ensuring primary angioplasty service 24/7 and fitting stents into a patient's heart within minutes of their arriving at the hospital, we are seeing higher risk patients arriving in the cath lab. The AutoPulse can provide consistent, uninterrupted chest compressions that may be more effective than manual CPR and more importantly, we can continue to screen while actively compressing," Brookes added. "Internationally, there are increasing reports of good outcomes in patients whose interventional procedure was performed during CPR. Plus, people get fatigued doing CPR. The AutoPulse gives us one less thing to worry about."
"Basingstoke and North Hampshire's installation of the AutoPulse to provide circulatory support during catheterizations will, we hope, be a key component of improving patient outcomes from sudden cardiac arrest and provide a good model for other NHS Foundation hospitals," said Jonathan Rennert, president of Zoll. "We're seeing more and more hospitals, both large and small, interested in AutoPulse for their cath labs."
The AutoPulse Non-invasive Cardiac Support Pump is an automated, portable device with an easy-to-use, load-distributing LifeBand that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest. The company believes the AutoPulse may offer a significant advantage over manual CPR, moving blood more consistently than human providers.
Precision obtains its 1st European patent
Precision Medical Devices (PMD; Fort Lauderdale, Florida) has obtained its first European patent. The company has applied for patent coverage of its unique bionic, telemetrically-controlled urethral valve device (designed to treat severe urinary incontinence, among other things) in most of the major industrialized countries in the world piggybacking on the five patents it has already obtained in the U.S.
PMD continues to apply for patent coverage in all of its other target markets for all of the U.S.-issued patents.
The company also has applied for additional U.S. patents, which are currently patent-pending, and continues to work on other proprietary product ideas, which may also be patentable.
The company said it expects that the current portfolio of six U.S. and six foreign patents, covering two products, with another product in the patent-pending stage, represent what is expected to be significant intrinsic value.